Phase II Iressa Versus Vinorelbine (INVITE)

PHASE2CompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

February 28, 2006

Conditions
Non-Small-Cell Lung Carcinoma
Interventions
DRUG

Gefitinib

DRUG

Vinorelbine

Trial Locations (55)

Unknown

Research Site, St Leonards

Research Site, Westmead

Research Site, South Brisbane

Research Site, Nedlands

Research Site, Victoria

Research Site, Fortaleza

Research Site, Goiânia

Research Site, Rio de Janeiro

Research Site, São Paulo

Research Site, Prague

Research Site, Ústí nad Labem

Research Site, Hradec Králové

Research Site, Kutná Hora

Research Site, Olomouc

Research Site, Ostrava

Research Site, Ostrava - Poruba

Research Site, Pilsen

Research Site, Marseille

Research Site, Montpellier

Research Site, Pierre-Bénite

Research Site, Vesoul

Research Site, Heidelberg

Research Site, Ulm

Research Site, München

Research Site, Hamburg

Research Site, Magdeburg

Research Site, Bad Segeberg

Research Site, Berlin

Research Site, Großhansdorf

Research Site, Halle

Research Site, Mainz

Research Site, La Torretta

Research Site, Bergamo

Research Site, Bologna

Research Site, Catania

Research Site, Melegnano

Research Site, Milan

Research Site, Rozzano

Research Site, Modena

Research Site, Parma

Research Site, Orbassano

Research Site, Torino

Research Site, Napoli

Research Site, Cape Town

Research Site, Durban

Research Site, Seoul

Research Site, Taichung

Research Site, Taipei

Research Site, Cambridge

Research Site, Birmingham

Research Site, Aberdeen

Research Site, Dundee

Research Site, Glasgow

Research Site, Nottingham

Research Site, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY